background image for GxP Lifeline
GxP Lifeline

What Biotech Startups Need to Do to Slay the Competition


Venture capitalists have pumped $2.8 billion into biotechnology startups in the first two months of this year alone (1). This means two things if you’re a startup. First, expect fierce competition because a huge capital pool attracts the very best in the industry. Second, this kind of investor confidence requires that you hit the ground running.

One of the biotech industry’s biggest stumbling blocks is unavoidable. There’s simply no way around the long development cycles for firms working on cutting-edge medicines and therapies. But there are many opportunities for you to improve R&D efficiency and to be ready to go.

In the past 12 years, I’ve had a chance to see up close how some biotech companies cleared the common hurdles for new companies. Most of them turned to my organization to reduce costs and improve compliance.

I would like to share with you two pivotal elements you are going to need to beat the competition. They are particularly crucial if you’re seeking capital investment or planning to sell your company down the road.


2016-nl-bl-author-matt-lowe

Matt Lowe has served MasterControl for nearly two decades across several different executive leadership roles including product, engineering, sales, and marketing, and now will continue his tenure as Chief Strategy Officer. In this role, Lowe brings vast institutional knowledge of the market, MasterControl’s products, and customers to identify growth strategies and expansion opportunities for the company. He also serves on the MasterControl Board of Directors.

Lowe is a medical device expert with experience in product development and product management at Ortho Development Corp. and Bard Access Systems, a subsidiary of BD. Lowe has successfully launched more than a dozen medical devices. He has five patents issued and one pending. His regulatory experience includes writing a 510(k) that was cleared by the FDA and managing a multi-site, multi-year post-market clinical study for orthopaedic devices.

Lowe has a bachelor's degree in mechanical engineering from the University of Utah and an MBA from Indiana University.


[ { "key": "fid#1", "value": ["GxP Lifeline Blog"] } ]